Australia's largest stock trading and investment forum Australia's #1 stock forum

SRX

Click for more information

0.00%

17.5¢ sierra rutile holdings limited

Ann: First Half Worldwide Dose Sales Growth of 5.6%, page-310

First 310 Last

Share
Profile

Follow
whytee

17,186 Posts.

2427

24/02/17

08:41

Post #: 22866038
Share

Originally posted by imback ↑

"IMO, SIRT will get OS benefit in all 3 trials. The question is will the benefit be large enough? If 4 months extra OS is required to be significant enough for 'win', and the result comes in at 3.8 months then said trial would be a 'fail'."

Cafa
Do the endpoints of the trial specify a target of >4 months OS or is that the general consensus for benefit required to justify clinical use ?

As you say, it is likely there will be a statistically significant difference which is the headline i would want to see in the case of a 3.8 month OS benefit . I would not want to see a 'failed to meet endpoint' for such a small miss.

Expand

The bar here is set very high for the primary endpoint, that's why it isn't a "shoo in". But if we win, we should win big.

SRX Price at posting: $16.48 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AR3

Overland drilling proves promising for Australian Rare Earths' uranium hopes

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Trump is President Again: What Does This Mean for Crypto?

CPV

ClearVue inks deal with UK heated glass player to combine solar tech with its offering

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

First 310 Last

Add SRX (ASX) to my watchlist